Press Releases

Upcoming Events

UBS Global Healthcare Conference 2019
Monday, May 20 - Wednesday, May 22

New York, NY

BIO International Convention 2019
Monday, June 03 - Thursday, June 06

Philadelphia, PA

> See all Events
July 27, 2017

The funding will be used to support discovery and preclinical development of a new class of antibiotic that circumvents beta-lactam antibiotic resistance, but with the same safe and effective mechanism of action of beta-lactams.

July 25, 2017

Proceeds will be used to advance the company’s portfolio, including lead product candidate VNRX-5133 for multi-drug resistant (MDR) gram-negative infections.

Archive: 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010